"Anti-Anxiety Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
| Descriptor ID |
D014151
|
| MeSH Number(s) |
D27.505.696.277.950.015 D27.505.954.427.210.950.015 D27.505.954.427.700.872.015
|
| Concept/Terms |
Anti-Anxiety Agents- Anti-Anxiety Agents
- Agents, Anti-Anxiety
- Anti Anxiety Agents
- Anxiolytic Agents
- Agents, Anxiolytic
- Tranquilizing Agents, Minor
- Agents, Minor Tranquilizing
- Minor Tranquilizing Agents
- Tranquillizing Agents, Minor
- Agents, Minor Tranquillizing
- Minor Tranquillizing Agents
- Anti-Anxiety Drugs
- Anti Anxiety Drugs
- Drugs, Anti-Anxiety
- Anxiolytics
Anti-Anxiety Effect- Anti-Anxiety Effect
- Anti Anxiety Effect
- Effect, Anti-Anxiety
- Anxiolytic Effects
- Effects, Anxiolytic
- Antianxiety Effects
- Effects, Antianxiety
- Anxiolytic Effect
- Effect, Anxiolytic
- Anti-Anxiety Effects
- Anti Anxiety Effects
- Effects, Anti-Anxiety
- Antianxiety Effect
- Effect, Antianxiety
|
Below are MeSH descriptors whose meaning is more general than "Anti-Anxiety Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Anxiety Agents".
This graph shows the total number of publications written about "Anti-Anxiety Agents" by people in this website by year, and whether "Anti-Anxiety Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 2 | 2 | 4 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 2 | 2 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 2 | 5 |
| 2003 | 1 | 1 | 2 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 2 | 3 |
| 2006 | 6 | 0 | 6 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Anxiety Agents" by people in Profiles.
-
Ari C, D'Agostino DP, Diamond DM, Kindy M, Park C, Kovács Z. Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements. J Vis Exp. 2019 01 07; (143).
-
Tucker Price S, DeCastro AO, Brock CD. Post-concussion syndrome and pre-existing mood disorder: A case report. Int J Psychiatry Med. 2019 05; 54(3):163-171.
-
Benich JJ, Bragg SW, Freedy JR. Psychopharmacology in Primary Care Settings. Prim Care. 2016 Jun; 43(2):327-40.
-
Sharko AC, Kaigler KF, Fadel JR, Wilson MA. Ethanol-induced anxiolysis and neuronal activation in the amygdala and bed nucleus of the stria terminalis. Alcohol. 2016 Feb; 50:19-25.
-
Jackson BF, Beck LA, Losek JD. Successful flumazenil reversal of paradoxical reaction to midazolam in a child. J Emerg Med. 2015 Mar; 48(3):e67-72.
-
Yusoff NH, Suhaimi FW, Vadivelu RK, Hassan Z, Rümler A, Rotter A, Amato D, Dringenberg HC, Mansor SM, Navaratnam V, Müller CP. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol. 2016 Jan; 21(1):98-110.
-
Winhusen TM, Kropp F, Lindblad R, Douaihy A, Haynes L, Hodgkins C, Chartier K, Kampman KM, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, May J, Brigham GS. Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry. 2014 Jul; 75(7):757-64.
-
Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, Schütz G, Chartoff EH, Rudolph U, Cohen BM, Carlezon WA. Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology. 2013 Jul; 38(8):1585-97.
-
Buffalari DM, Baldwin CK, See RE. Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats. Psychopharmacology (Berl). 2012 Sep; 223(2):179-90.
-
Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol Res. 2012; 34(4):414-31.